Niels Frost Andersen

Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

Michèle Cavo, Francesca Gay, Meral Beksaç et al. · The Lancet Haematology · 2020 · 377 citations · Full text

Hematological Malignancy, Transplantation, Marrow Transplantation +9

Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

Ulf‐Henrik Mellqvist, Peter Gimsing, Øyvind Hjertner et al. · Blood · 2013 · 143 citations · Full text

Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial

Peter Gimsing, Kristina Carlson, Ingemar Turesson et al. · The Lancet Oncology · 2010 · 117 citations · Full text

Bone Disease, Hematological Malignancy, Bone Health +8

Syndecan‐1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival

Niels Frost Andersen, Therese Standal, Johan Lanng Nielsen et al. · British Journal of Haematology · 2004 · 91 citations

Hematological Malignancy, Angiogenesis, Bone Marrow Levels +13

Diagnostic Accuracy of [11C]PIB Positron Emission Tomography for Detection of Cardiac Amyloidosis

Sara Rosengren, Tor Skibsted Clemmensen, Lars Poulsen Tolbod et al. · JACC. Cardiovascular imaging · 2020 · 88 citations

Positron Emission Tomography, Alzheimer's Disease, Cardiac Amyloidosis +10